Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination

Most existing studies characterizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses are peptide based. This does not allow evaluation of whether tested peptides are processed and presented canonically. In this study, we use recombinant vaccinia virus (rVACV)-m...

Full description

Saved in:

Bibliographic Details
Published in:	Cell reports (Cambridge) Vol. 42; no. 5; p. 112470
Main Authors:	Yin, Zixi, Chen, Ji-Li, Lu, Yongxu, Wang, Beibei, Godfrey, Leila, Mentzer, Alexander J., Yao, Xuan, Liu, Guihai, Wellington, Dannielle, Zhao, Yiqi, Wing, Peter A.C., Dejnirattisa, Wanwisa, Supasa, Piyada, Liu, Chang, Hublitz, Philip, Beveridge, Ryan, Waugh, Craig, Clark, Sally-Ann, Clark, Kevin, Sopp, Paul, Rostron, Timothy, Mongkolsapaya, Juthathip, Screaton, Gavin R., Ogg, Graham, Ewer, Katie, Pollard, Andrew J., Gilbert, Sarah, Knight, Julian C., Lambe, Teresa, Smith, Geoffrey L., Dong, Tao, Peng, Yanchun
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 30.05.2023 Cell Press Elsevier
Subjects:	Antibodies, Viral antigen processing and presentation ChAdOx1 nCoV-19 COVID-19 CP: Immunology Humans immune escape recombinant vaccinia virus SARS-CoV-2 spike protein T cell Vaccination variants of concern CP: Immunology SARS-CoV-2 variants of concern T cell spike protein recombinant vaccinia virus antigen processing and presentation immune escape ChAdOx1 nCoV-19
ISSN:	2211-1247, 2211-1247
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!